Post-meal coagulation activation in diabetes mellitus: The effect of acarbose

被引:73
作者
Ceriello, A
Taboga, C
Tonutti, L
Giacomello, R
Stel, L
Motz, E
Pirisi, M
机构
[1] UDINE GEN HOSP,DIABETOL UNIT,UDINE,ITALY
[2] UNIV UDINE,CHAIR CLIN PATHOL,DEPT PATHOL & MED,I-33100 UDINE,ITALY
关键词
meal; hyperglycaemia; thrombophilia; prothrombin fragments 1 + 2; D-dimer; acarbose;
D O I
10.1007/s001250050467
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It has been previously demonstrated that hyperglycaemia activates haemostasis; diabetes mellitus is considered a thrombosis-prone state. Acarbose, by inhibiting dietary carbohydrate absorption, reduces post-meal hyperglycaemia. In this study we. evaluated the effect of post-meal hyperglycaemia on two markers of coagulation activation: prothrombin fragments 1+2 and D-dimer. Seventeen non-insulin-dependent diabetic patients maintained on diet therapy alone were randomly assigned to receive - with a cross-over study design - acarbose (100 mg orally) or placebo before a standard meal. Blood samples for measurement of plasma glucose, insulin, prothrombin fragments 1+2 and D-dimer were drawn at 0, 60, 120 and 240 min. After both placebo and acarbose, hyperglycaemia and hyperinsulinaemia which followed a standard meal were accompanied by a significant increase of plasma concentration of prothrombin fragments 1+2 and D-dimer in comparison to their baseline values. Acarbose administration significantly reduced the rise of glucose, insulin, prothrombin fragments 1+2 and D-dimer from 0 to 240 min in comparison to placebo. We conclude that post-meal hyperglycaemia, at the level reached by many diabetic patients on diet therapy alone, induces a coagulation activation, Acarbose, by decreasing post-meal hyperglycaemia, may be useful in reducing meal-induced activation of haemostasis in diabetic patients.
引用
收藏
页码:469 / 473
页数:5
相关论文
共 38 条
[1]  
Altmann DG, 1991, PRACTICAL STAT MED R, P440
[2]   GENERATION OF COMBINED PROTHROMBIN ACTIVATION PEPTIDE (F1.2) DURING CLOTTING OF BLOOD AND PLASMA [J].
ARONSON, DL ;
STEVAN, L ;
BALL, AP ;
FRANZA, BR ;
FINLAYSON, JS .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 60 (06) :1410-1418
[3]   IS BORDERLINE FASTING HYPERGLYCEMIA A RISK FACTOR FOR CARDIOVASCULAR DEATH [J].
BARRETTCONNOR, E ;
WINGARD, DL ;
CRIQUI, MH ;
SUAREZ, L .
JOURNAL OF CHRONIC DISEASES, 1984, 37 (9-10) :773-779
[4]   ASSESSMENT OF HYPERCOAGULABLE STATES BY MEASUREMENT OF ACTIVATION FRAGMENTS AND PEPTIDES [J].
BOISCLAIR, MD ;
IRELAND, H ;
LANE, DA .
BLOOD REVIEWS, 1990, 4 (01) :25-40
[5]   FIBRINOGEN PLASMA-LEVELS AS A MARKER OF THROMBIN ACTIVATION IN DIABETES [J].
CERIELLO, A ;
TABOGA, C ;
GIACOMELLO, R ;
FALLETI, E ;
DESTASIO, G ;
MOTZ, E ;
LIZZIO, S ;
GONANO, F ;
BARTOLI, E .
DIABETES, 1994, 43 (03) :430-432
[6]  
CERIELLO A, 1992, HAEMOSTASIS, V22, P50
[7]  
CERIELLO A, 1993, DIABETES METAB, V19, P225
[8]   COAGULATION ACTIVATION IN DIABETES-MELLITUS - THE ROLE OF HYPERGLYCEMIA AND THERAPEUTIC PROSPECTS [J].
CERIELLO, A .
DIABETOLOGIA, 1993, 36 (11) :1119-1125
[9]   HYPERGLYCEMIA-INDUCED THROMBIN FORMATION IN DIABETES - THE POSSIBLE ROLE OF OXIDATIVE STRESS [J].
CERIELLO, A ;
GIACOMELLO, R ;
STEL, G ;
MOTZ, E ;
TABOGA, C ;
TONUTTI, L ;
PIRISI, M ;
FALLETI, E ;
BARTOLI, E .
DIABETES, 1995, 44 (08) :924-928
[10]  
CERIELLO A, 1988, DIABETOLOGIA, V31, P889